Microarray System with Analysis Package

The U.S. Food and Drug Administration (FDA), specifically the Center for Biologics Evaluation and Research (CBER), is seeking to procure one Microarray System with Analysis Package through a Request for Quote (RFQ) to measure the potency of neuraminidase components in influenza vaccines and support vaccine licensure and pandemic preparedness efforts. The system must be capable of simultaneously analyzing all hemagglutinin (HA) or neuraminidase (NA) subtypes in multiplexed vaccine products within a single workday and must demonstrate assay sensitivity at or below 1 microgram/mL. Key contract requirements include the delivery of specified assay kits (10 OmniFlu HA 96 Assay Kits, 10 VaxArray Influenza Seasonal NA Multivalent Assay Kits v2.0, 20 Influenza A&B pAb Detection Labels, and 10 Influenza NA A&B pAb Detection Labels), automated data analysis software compatible with Windows 10, storage and washing equipment, at least one year of warranty, and onsite installation, qualification, and training services. The contract will be awarded on a Firm-Fixed Price basis to the lowest price technically acceptable and responsible offeror. All quotes must be submitted by email to howard.nesmith@fda.hhs.gov by 1:00 PM Central Time on April 10, 2026, and must include an Accessibility Conformance Report addressing Section 508 ICT accessibility standards.

This solicitation is set aside exclusively for small businesses under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing) with a 1,000-employee threshold, and responses must include active SAM.gov registration at the time of submission. No specific incumbent contractor or award value range is identified in the solicitation materials. The procurement involves a comprehensive package that includes delivery, installation, and training services with all costs quoted on an FOB destination basis to Silver Spring, Maryland. Payment will be made on a Net 30-day basis following government acceptance, with invoices submitted electronically through the Department of Treasury's Invoice Processing Platform (IPP). The place of performance is Silver Spring, MD 20993, and interested contractors must meet all technical and compliance requirements outlined in the Combined Synopsis/Solicitation document.